Evidence map›Paper›PMID 28702856›Full record

ArticleMedical microbiology and immunology2017

Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.

Ramona Gilles, Marco Herling, Udo Holtick, Eva Heger, Sabine Awerkiew, Irina Fish, Konstantin Höller, Saleta Sierra, Elena Knops, Rolf Kaiser and 2 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07286461 (VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07286461 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

TypeobservationalSponsorUniversity of Rome Tor VergataRan2025 to 2027Enrolled290ConditionsAllogeneic Hematopoietic Stem Cell Transplantation Recipient, CMVArmsletermovir prophylaxis
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ramona GillesInstitute of Virology, University of Cologne, Cologne, Germany.
Marco HerlingDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Udo HoltickDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Eva HegerInstitute of Virology, University of Cologne, Cologne, Germany.
Sabine AwerkiewInstitute of Virology, University of Cologne, Cologne, Germany.
Irina FishInstitute of Virology, University of Cologne, Cologne, Germany.
Konstantin HöllerInstitute of Virology, University of Cologne, Cologne, Germany.
Saleta SierraInstitute of Virology, University of Cologne, Cologne, Germany.
Elena KnopsInstitute of Virology, University of Cologne, Cologne, Germany.
Rolf KaiserInstitute of Virology, University of Cologne, Cologne, Germany.
Christof ScheidDepartment I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Veronica Di CristanzianoInstitute of Virology, University of Cologne, Cologne, Germany. veronica.di-cristanziano@uk-koeln.de.ORCID http://orcid.org/0000-0003-1604-8386
University of Cologne · DEUniversity Hospital Cologne · DETH Köln - University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment option for several hematological diseases. However, the first year post-transplantation is often complicated by infections and graft-versus-host disease (GVHD). Improvements in immunological monitoring could reduce such post-transplant complications. Torque Teno virus (TTV), a chronically persisting DNA virus, is reported to be a marker for immune function in immunocompromised patients. In the present study, the TTV kinetics were analyzed to investigate the potential role of TTV viremia as immune-competence read-out after allo-HSCT. Twenty-three monocentric allo-HSCT recipients were retrospectively tested for TTV-DNA in whole blood at given day post-transplant. Dynamics of TTV viremia was analyzed with respect to episodes of non-TTV viral reactivations (CMV, EBV, and BKPyV), acute GVHD, and recovery of immune cells. Recipients affected by persisting viral infections and/or GVHD during the first 100 days after allo-HSCT showed a significantly higher median TTV load at day +30 than patients with a less complicated clinical course (p = 0.005). This was also associated with a total lymphocyte count <5.5E+08 cells/L in this high-risk group (p = 0.039). These findings suggest that TTV could represent an additional parameter to identify patients at higher risk for complications in the first 100 days following allo-HSCT. Prospective studies, including the monitoring of lymphocyte subsets, are required to define the potential use of TTV in immunological monitoring after allo-HSCT.

Indexed as

Viral LoadAdultAgedFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk AssessmentTorque teno virusTransplantation, HomologousVirus DiseasesAllogeneic hematopoietic stem cell transplantationGVHDTTVViral reactivation

Identifiers

PMID28702856
OpenAlexW2735946133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.